Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.
Intermittent alien hand syndrome and callosal apraxia in multiple sclerosis: implications for interhemispheric communication.
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.
High-Throughput Screening Platform for the Discovery of New Immunomodulator Molecules from Natural Product Extract Libraries.
Demyelinating disease: Novel markers for disease severity in neuromyelitis optica.
[The possibility of using music therapy in neurology on the example of multiple sclerosis].
Principal components of functional connectivity: A new approach to study dynamic brain connectivity during rest.
Hunting for autoantibodies in multiple sclerosis.
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
Anti-myelin antibodies play an important role in the susceptibility to develop PLP-induced EAE.
Severe exacerbation of psoriasis after intravenous immunoglobulin in patient with multiple sclerosis that started during biologic therapy.
Blocking GluR2-GAPDH ameliorates experimental autoimmune encephalomyelitis.
Potential of Urinary Metabolites for Diagnosing Multiple Sclerosis.
Abstracts.
Reproducibility of brain metabolite concentration measurements in lesion free white matter at 1.5 T.
Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury.
MOG-induced experimental autoimmune encephalomyelitis in the rat species triggers anti-neurofascin antibody response that is genetically regulated.
Adjusted Indirect Comparison of Oral Multiple Sclerosis Agents.
Biochemical Pharmacology of the Sigma-1 Receptor.
Prevalence of Classic and Non-Classic Antiphospholipid Antibodies in Multiple Sclerosis.
Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.
Ocular motor signatures of cognitive dysfunction in multiple sclerosis.
Remyelination of the Corpus Callosum by Olfactory Ensheathing Cell in an Experimental Model of Multiple Sclerosis.
Disease-modifying agents in multiple sclerosis.
Pages
« first
‹ previous
…
572
573
574
575
576
577
578
579
580
…
next ›
last »